Description

IBRUMED 140MG (1X30)

Indications

IBRUMED 140MG is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. It is also used in the treatment of acute pain episodes, including post-operative pain and dental pain. The formulation is designed to provide effective relief while minimizing the risk of gastrointestinal side effects commonly associated with non-steroidal anti-inflammatory drugs (NSAIDs).

Mechanism of Action

The active ingredient in IBRUMED is ibuprofen, a non-selective NSAID. Its mechanism of action involves the inhibition of cyclooxygenase (COX) enzymes, which are crucial in the biosynthesis of prostaglandins. By reducing the production of these inflammatory mediators, ibuprofen effectively alleviates pain and inflammation. The drug also exhibits antipyretic properties, helping to reduce fever by acting on the hypothalamic heat-regulating center.

Pharmacological Properties

IBRUMED 140MG is characterized by its rapid absorption and distribution in the body. Peak plasma concentrations are typically reached within 1-2 hours after oral administration. The drug is metabolized primarily in the liver, with its metabolites excreted via the kidneys. The half-life of ibuprofen is approximately 2 hours, which allows for flexible dosing schedules. The formulation is designed for oral use and is available in tablet form, ensuring ease of administration.

Contraindications

IBRUMED 140MG is contraindicated in patients with known hypersensitivity to ibuprofen or any other components of the formulation. It should not be used in individuals with a history of gastrointestinal bleeding, peptic ulcer disease, or severe renal impairment. Additionally, patients with active or suspected cardiovascular disease, particularly those with a history of myocardial infarction or stroke, should avoid using this medication unless under strict medical supervision.

Side Effects

Common side effects associated with IBRUMED 140MG include gastrointestinal disturbances such as nausea, vomiting, dyspepsia, and diarrhea. Patients may also experience headache, dizziness, or rash. Serious side effects, although rare, can include gastrointestinal bleeding, renal impairment, and hypersensitivity reactions such as anaphylaxis. It is essential for patients to be aware of these potential adverse effects and to seek medical attention if they experience severe or persistent symptoms.

Dosage and Administration

The recommended dosage of IBRUMED 140MG varies based on the condition being treated and the patient’s age. For adults, the typical starting dose is 400mg taken every 6-8 hours as needed, not exceeding 1200mg per day. For children, dosing is based on body weight, and it is crucial to follow the pediatrician’s guidance. The tablets should be taken with food or milk to minimize gastrointestinal irritation. Patients should not exceed the recommended dosage and should consult their healthcare provider if symptoms persist or worsen.

Interactions

IBRUMED 140MG may interact with several medications, potentially altering their effects. Co-administration with other NSAIDs or anticoagulants can increase the risk of gastrointestinal bleeding. Additionally, ibuprofen may reduce the effectiveness of antihypertensive medications, such as ACE inhibitors and diuretics. It is important for patients to inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to avoid potential drug interactions.

Precautions

Patients should exercise caution when using IBRUMED 140MG, especially those with pre-existing medical conditions such as asthma, liver disease, or hypertension. Regular monitoring of renal function is recommended for patients on long-term therapy. Pregnant and breastfeeding women should consult their healthcare provider before using this medication, as ibuprofen may pose risks to the fetus or nursing infant. It is advisable to use the lowest effective dose for the shortest duration necessary to manage symptoms.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy and safety of ibuprofen in managing pain and inflammation. A randomized controlled trial published in the Journal of Pain Research highlighted that ibuprofen significantly reduced pain scores in patients with osteoarthritis compared to placebo. Another study in the American Journal of Medicine reported that ibuprofen effectively alleviated post-operative pain, with a favorable safety profile when used as directed. These studies underscore the importance of ibuprofen as a first-line treatment option for various pain conditions.

Conclusion

IBRUMED 140MG is a well-established medication for the management of pain and inflammation. Its efficacy, combined with a favorable safety profile when used appropriately, makes it a valuable option for patients suffering from various painful conditions. However, it is essential for users to adhere to recommended dosages, be aware of potential side effects, and consult healthcare professionals regarding any concerns or pre-existing conditions. Responsible use of IBRUMED 140MG can lead to effective pain management and improved quality of life for many patients.